dismiss

Clean Sweep Live Auction on Wed. February 27th. Click to view the full inventory

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment
Advertisement

 

advertisement

 

Cardiology Homepage

John D. Zehren Endologix appoints chief commercial officer

Medtronic to acquire EPIX Therapeutics Will use EPIX's cardiac ablation technology with Medtronic's cryoballoon technology

Centerline Biomedical submits IOPS system for FDA clearance Designed as alternative to X-ray fluoroscopy

Philips unveils Azurion angiography system with FlexArm positioning System moves on eight different axes with single controller

FDA clears RFPi's iCertainty blood flow and perfusion imaging solution No injections, dyes, radiation, direct patient contact or interruptions in procedures

Rob Beanlands ASNC names president for 2019

FDA gives nod to new clearance for iSchemaView’s RAPID platform Can help select which stroke patients require clot removal procedures

Hill-Rom Holdings launches LINQ Mobile App that connects care team members to one another, patients and patient info in real time

FDA gives green light for Edwards' SAPIEN 3 Ultra system Provides transcatheter aortic valve replacement to patients facing surgical risks

Boston Scientific to acquire shares of Millipede for $325 million Initially bought $90 million worth of shares a year ago

Jeffrey S. Brown

Endologix appoints chief operations officer
August 31, 2018
IRVINE, Calif.--(BUSINESS WIRE)--Endologix, Inc. (Nasdaq:ELGX) (“Endologix” or the “Company”), a developer and marketer of innovative treatments for aortic disorders, today announced that it has appointed Jeffrey S. Brown as the Company’s Chief Operations Officer, effective as of August 13, 2018.

John Onopchenko, Chief Executive Officer of Endologix, Inc., said, “I am very excited to have someone with Jeff’s credentials and industry knowledge joining our executive team. His proven track record of transformational leadership, operational excellence, and delivering results will be invaluable to Endologix. We remain focused on building a cohesive team and a strong culture of accountability, while continuing to innovate and position the Company for further operational improvements.”

Story Continues Below Advertisement

Has exclusive distribution agreement with DDD to sell new Camera systems

UMRi provides the very best new & refurbished gamma cameras, quality parts &repair services. We also rebuild & replace camera detectors, move camera systems across town or across the country. Call us at 888-239-3510



Mr. Brown brings to Endologix twenty four years of experience as a General Manager, Chief Operating Officer, Supply Chain Executive, Sales Leader, Consultant and Lecturer. Most recently, he was General Manager of a multi-site joint venture between Johnson & Johnson and Steris Corporation, where he led significant improvements across operations, quality, engineering, and supply chain. Prior to that, he was Chief Operating Officer for Chatham Industries, where he helped successfully orchestrate a leveraged buyout and turnaround of the firm. Prior to that, Mr. Brown worked for five years as General Manager at Boston Scientific Corporation, where he led a critical site transformation and sat on the global supply chain management board. Mr. Brown also worked for seven years as Worldwide Operations Manager at Johnson & Johnson and for five years leading sterilization operations across the U.S., EU, and Far East for Haemonetics Corporation.

Mr. Brown commented, ”I am thrilled to be taking on this critical leadership role at Endologix, particularly during this transformational time. I look forward to working with the team to improve operations and to leverage our talent and innovative technology, with the ultimate goal of delivering superior products and services to our patients.”

Mr. Brown earned his MBA from Babson College, Wellesley, MA and his Bachelor of Science in Microbiology from University of New Hampshire, Durham, NH.


About Endologix, Inc.
Endologix, Inc. develops and manufactures minimally invasive treatments for aortic disorders. The Company's focus is endovascular stent grafts for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. The overall patient mortality rate for ruptured AAA is approximately 80%, making it a leading cause of death in the United States.

Back to HCB News
  Pages: 1

Cardiology Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.
ALL RIGHTS RESERVED